| h-f19b8ac8 | Complement-Mediated Synaptic Protection | 0.58 | 0.40 | C1QA | debated | 2026-04-04 | SDA-2026-04-04-gap-20260404-microglial-priming-early-ad |
| h-45d23b07 | Multi-Biomarker Composite Index Surpassing Amyloid PET for Treatment Response Pr | 0.58 | 0.45 | COMPOSITE_BIOMARKER | promoted | 2026-04-17 | SDA-BIOMNI-BIOMARKE-34ec007c |
| h-6880f29b | IGFBPL1-Mediated Microglial Reprogramming | 0.58 | 0.40 | IGFBPL1 | debated | 2026-04-04 | SDA-2026-04-04-gap-20260404-microglial-priming-early-ad |
| h-var-fe8899ff37 | TREM2-Astrocyte Communication in Microglial Dysfunction | 0.58 | 0.53 | TREM2 | promoted | 2026-04-21 | SDA-2026-04-03-gap-aging-mouse-brain-v3-20260402 |
| h-0bdc3803 | Spatial Transcriptome-Guided Precision Cell Therapy | 0.58 | 0.55 | SOX10 and DLX1/2 | proposed | 2026-04-04 | SDA-2026-04-03-gap-seaad-v2-20260402032945 |
| h-8e3748fe5c | Chronic mTORC1-ULK1 signaling blocks autophagy initiation in irradiated pericyte | 0.58 | 0.49 | MTOR | proposed | 2026-04-26 | SDA-2026-04-26-gap-pubmed-20260410-193006-9525a13b-debate |
| h-fbc439901e | NAD+/SARM1 Axis Provides Metabolic Feedback Coupling Mitophagy to ER-Phagy | 0.58 | 0.52 | SARM1 (SARM1), PARP1, SIRT1, SIRT3 | proposed | 2026-04-21 | SDA-2026-04-07-gap-pubmed-20260406-062132-e71b3ef7 |
| h-73e29e3a | Synaptic Vesicle Tau Capture Inhibition | 0.58 | 0.34 | SNAP25 | archived | 2026-04-02 | SDA-2026-04-04-gap-tau-prop-20260402003221 |
| h-665d562cbf | Astrocyte reactivity subtypes in neurodegeneration — Rich Analysis Notebook shou | 0.58 | 0.52 | Astrocyte | proposed | 2026-04-28 | SDA-2026-04-27-gap-methodol-20260427-035148-9ab1842d |
| h-50249eb28d | Mitochondrial transfer between neurons and glia — Rich Analysis Notebook should | 0.58 | 0.52 | Mitochondrial | proposed | 2026-04-28 | SDA-2026-04-27-gap-methodol-20260427-035148-7b3b3df4 |
| h-bfcbb20cff | TREM2 should remain under review until replicated | 0.58 | 0.52 | tau | proposed | 2026-04-28 | AD-MASTER-PLAN-TREM2-20260428030753 |
| h-f12d206863 | APOE should remain under review until replicated | 0.58 | 0.52 | tau | proposed | 2026-04-28 | AD-MASTER-PLAN-APOE-20260428030754 |
| h-1cfdb2339d | BDNF should remain under review until replicated | 0.58 | 0.52 | tau | proposed | 2026-04-28 | AD-MASTER-PLAN-BDNF-20260428030755 |
| h-d6c8b66717 | GFAP should remain under review until replicated | 0.58 | 0.52 | tau | proposed | 2026-04-28 | AD-MASTER-PLAN-GFAP-20260428030756 |
| h-c092c61024 | LRP1 should remain under review until replicated | 0.58 | 0.52 | tau | proposed | 2026-04-28 | AD-MASTER-PLAN-LRP1-20260428030757 |
| h-9a9ad9ae54 | microglial priming across neurodegenerative diseases should remain under review | 0.58 | 0.52 | C1QA | proposed | 2026-04-28 | SDA-2026-04-28-microglial-priming-causal-nd |
| h-0452017800 | SciDEX debate-engine causal discovery benchmark should remain under review until | 0.58 | 0.52 | calibration | proposed | 2026-04-28 | SDA-causal-benchmark-20260428-035713 |
| h-7204d85a33 | Mitochondrial transfer between neurons and glia — Rich Analysis Notebook should | 0.58 | 0.52 | Mitochondrial | proposed | 2026-04-28 | SDA-2026-04-28-gap-methodol-20260427-035148-7b3b3df4 |
| h-d773e0bf21 | H4: Age-Related Hsp70 Chaperone Decline Blocks Granule Reversibility | 0.58 | 0.58 | HSPA1A/HSPA1B, DNAJB6, DNAJB8 | proposed | 2026-04-22 | SDA-2026-04-06-gap-pubmed-20260406-041428-4c4414ad |
| h-4c10f3df93 | TBK1 Phosphorylation State Creates Phospho-Regulated Peripheral Retention Thresh | 0.58 | 0.50 | TBK1 | proposed | 2026-04-21 | SDA-2026-04-08-gap-pubmed-20260406-041423-9c2c2ee3 |
| h-var-0dd032612f | Dynamic Microglial Phenotype Switching Biomarker Panel for Neuroinflammatory Tre | 0.58 | 0.42 | TREM2 | promoted | 2026-04-20 | SDA-2026-04-16-gap-pubmed-20260410-192526-f2bbb9ab |
| h-7c80747e | Hepcidin-Iron Set Point Hypothesis | 0.58 | 0.55 | | proposed | 2026-04-14 | SDA-2026-04-13-gap-pubmed-20260410-155308-2c6815fb |
| h-b6167641 | TDP-43 Cryptic Exon–Targeted ASOs to Restore Hippocampal Gamma Oscillations | 0.58 | 0.55 | TARDBP (TDP-43) / cryptic splice sites in GABAergic transcri | promoted | 2026-04-13 | SDA-2026-04-13-gap-20260410-172514 |
| h-dc505f6346 | TREM2 Promoter Silencing via DNA Hypermethylation | 0.58 | 0.68 | TREM2 | proposed | 2026-04-21 | SDA-2026-04-07-gap-debate-20260406-062045-56983337 |
| h-d7849fd300 | Closed-Loop Hippocampal TFUS for Gamma Network Target Engagement | 0.58 | 0.45 | CCK (cholecystokinin), TREK-1 (KCNK2), TRPV4 | proposed | 2026-04-28 | SRB-2026-04-28-h-var-a4975bdd96 |
| h-375c093a3f | APOE4 dual function: beneficial astrocyte anti-inflammatory signaling vs. pathog | 0.57 | 0.68 | APOE | proposed | 2026-04-27 | SDA-2026-04-12-gap-pubmed-20260410-184126-b2c3e2e8 |
| h-241752cd | CD38 Inhibition for NAD+ Restoration and Microglial Senescence Prevention | 0.57 | 0.55 | CD38 | proposed | 2026-04-26 | SDA-2026-04-17-gap-microglial-subtypes-pharmaco-202604170000 |
| h-d27b354c | Sequential TRPML1 Activation Following Autophagy Priming | 0.57 | 0.60 | MCOLN1 (TRPML1), ATG7 | promoted | 2026-04-16 | SDA-2026-04-16-gap-debate-20260410-113045-27c7b314 |
| h-0f00fd75 | HSP90-Tau Disaggregation Complex Enhancement | 0.57 | 0.53 | HSP90AA1 | archived | 2026-04-02 | SDA-2026-04-04-gap-tau-prop-20260402003221 |
| h-var-a4ec87f152 | TREM2-Senescence Cascade in Astrocyte-Microglia Communication Breakdown | 0.57 | 0.53 | TREM2 | promoted | 2026-04-21 | SDA-2026-04-03-gap-aging-mouse-brain-v3-20260402 |
| h-analogy-90a0279a | Astrocyte-targeted LNP-APOE4 silencing to restore lipid homeostasis and suppress | 0.57 | 0.45 | APOE | active | 2026-04-28 | |
| h-var-58e76ac310 | Closed-loop transcranial focused ultrasound with 40Hz gamma entrainment to resto | 0.57 | 0.81 | PVALB | promoted | 2026-04-12 | SDA-2026-04-03-26abc5e5f9f2 |
| h-ea3274ff | TREM2-P2RY12 Balance Restoration Therapy | 0.57 | 0.30 | TREM2 | debated | 2026-04-04 | SDA-2026-04-04-gap-20260404-microglial-priming-early-ad |
| h-298d27a24f | Disease-Associated Microglia (DAM) Program Drives IBA1 Downregulation | 0.57 | 0.50 | TREM2/TYROBP | proposed | 2026-04-21 | SDA-2026-04-07-gap-pubmed-20260406-041439-306c2cdb |
| h-35d17c0074 | VPS34 Complex I Subunit Heterogeneity Dictates Organelle-Specific vs. Bulk Autop | 0.57 | 0.55 | PIK3C3/VPS34, ATG14L, UVRAG, NRBF2 | proposed | 2026-04-21 | SDA-2026-04-07-gap-pubmed-20260406-062132-e71b3ef7 |
| h-var-b9a3903f4c | PINK1/PARK2-Mediated Mitophagy Enhancement for Neuroinflammation Control | 0.57 | 0.41 | PINK1 | promoted | 2026-04-20 | SDA-2026-04-03-gap-immune-atlas-neuroinflam-20260402 |
| h-b7ab85b6 | Neuronal Subtype-Specific Alpha-Synuclein Expression Normalization | 0.57 | 0.40 | SNCA | proposed | 2026-04-04 | SDA-BIOMNI-BINDER_D-0657a9ed |
| h-cee6b095 | REST Complex Dysregulation as Master Epigenetic Switch | 0.57 | 0.60 | REST | proposed | 2026-04-26 | SDA-2026-04-19-gap-epigenetic-comparative-ad-pd-als |
| h-7b7218698d | Blocking Exosomal Tau Uptake at Neuronal LRP1 Receptors Disrupts Interneuronal P | 0.57 | 0.60 | LRP1 | proposed | 2026-04-22 | SDA-2026-04-04-gap-20260404-052358 |
| h-fd8eb2a065 | Blocking Astrocyte-Mediated Tau Re-Spreading via Cx43 Hemichannel Inhibition | 0.57 | 0.52 | GJA1 (Connexin-43) | proposed | 2026-04-22 | SDA-2026-04-04-gap-tau-prion-spreading |
| h-514ab2e42b | Hsp70-based therapy to prevent lysosomal membrane permeabilization and cathepsin | 0.57 | 0.55 | HSPA1A | proposed | 2026-04-22 | SDA-2026-04-04-gap-lysosomal-cathepsin-ad |
| h-eaee030e68 | CX3CR1-Negative Trem2-High Microglial Subset Mediates Female Resilience via Estr | 0.57 | 0.62 | ESR1 | proposed | 2026-04-22 | SDA-2026-04-06-gap-pubmed-20260406-041439-ec89b1e4 |
| h-e047388d70 | LRP1-mediated synaptic uptake drives early entorhinal-hippocampal tau propagatio | 0.57 | 0.62 | LRP1 | proposed | 2026-04-21 | SDA-2026-04-07-gap-debate-20260406-062052-946439a8 |
| h-0eec787493 | Direct NF-κB Transcriptional Regulation of C1q Genes in Microglia | 0.57 | 0.58 | RELA; C1QA/C1QB/C1QC | proposed | 2026-04-21 | SDA-2026-04-08-gap-pubmed-20260406-062128-afe67892 |
| h-5c618b582c | Brain-Ester Prodrug Strategy for CNS-Selective HDAC6 Inhibition | 0.57 | 0.65 | HDAC6 (class IIb histone deacetylase) | proposed | 2026-04-21 | SDA-2026-04-08-gap-debate-20260406-062039-47e9c8cf |
| h-var-2041072461 | TREM2-Dependent Microglial Surveillance Controls AQP4-Mediated Tau Clearance Thr | 0.57 | 0.71 | TREM2 | proposed | 2026-04-12 | SDA-2026-04-03-26abc5e5f9f2 |
| h-var-1906e102cf | Dual-Circuit Tau Vulnerability Cascade with Glial-Mediated Amplification | 0.57 | 0.65 | MAPT | proposed | 2026-04-07 | SDA-2026-04-03-26abc5e5f9f2 |
| h-06d5f49673 | Conserved G-Quadruplex Forming Potential in HOTAIR Defines Therapeutic Window | 0.57 | 0.52 | HOTAIR | proposed | 2026-04-21 | SDA-2026-04-10-gap-debate-20260410-075007-232fbf62 |
| h-e12109e3 | Tau-Independent Microtubule Stabilization via MAP6 Enhancement | 0.57 | 0.60 | MAP6 | debated | 2026-04-02 | sda-2026-04-01-gap-004 |
| h-4107efb8ea | Vascular and Perivascular Cell Type Vulnerability: BBB Integrity Disruption | 0.57 | 0.71 | CLDN5 | proposed | 2026-04-22 | SDA-2026-04-02-gap-seaad-debate-v4 |